Lunai Bioworks Inc. — Director's Dealing 2021

Dec 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2020-04-06

Reporting Person: Alton Gregg H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-28	Option to purchase shares of common stock	$2.95	A	25424	Acquired	2030-12-28	Common stock (25.424)	Direct
2020-04-06	Option to purchase shares of common stock	$4.80	A	15625	Acquired	2030-04-06	Common stock (15625)	Direct

Footnotes

F1: On December 3, 2020, Mr. Alton was granted an option to purchase 25,424 shares of common stock of Enochian Biosciences Inc., said option to vest on December 28, 2021.

F2: On April 6, 2020, Mr. Alton was granted an option to purchase 15,625 shares of common stock of Enochian Biosciences Inc., said option to vest on December 27, 2020.